Unicycive Therapeutics (NASDAQ:UNCY) just reported results for the fourth quarter of 2023.
- Unicycive Therapeutics reported earnings per share of -35 cents. This was below the analyst estimate for EPS of -17 cents.
- The company did not report any revenue for the quarter.